CD19 and neoplasm: Although the majority of malignant cells are eliminated during subsequent cell culture and CAR-T-cell preparation processes, if CD19-CAR is expressed in tumor cells, it can artificially block the CD19 antigen in tumor cells, preventing recognition and clearance by CD19-CAR-T cells and resulting in fatal CAR Tumor cells (Figures 5, 6) (54).